BBNX

BBNX R&D to Revenue

34.70%Fiscal year

Period ending:

BBNX FY R&D/Revenue%
BBNX FY R&D/Revenue19660.28%-2068.04%
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

BBNX r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Beta Bionics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
34.7019%
40.2064%
149.5873%
17,557.5419%

Compare r&d to revenue

All BBNX financial metrics · BBNX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.